Biogen selects Cognizant’s SmartTrials Platform

Friday, July 1, 2016

Biogen has selected Cognizant‘s SmartTrials platform to aggregate and store clinical trial operational and patient data. Cambridge, Mass.-based Biogen has a portfolio of medicines to treat multiple sclerosis (MS) and is at the forefront of neurology research, working to develop novel therapies for conditions with few or no treatment options.

[Read More]